Covered recipient · General Payments record
OLIVER LYNN SMYTH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,363.70
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.18 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $81.01 | 3 |
| Novo Nordisk AS | $61.39 | 3 |
| CHIESI USA, INC. | $22.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.15 | 1 |
| PFIZER INC. | $19.55 | 1 |
| Amgen Inc. | $19.36 | 1 |
| Acerta Pharma LLC | $16.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.36 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117386808 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.93 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104354898 | CMS |
| Chiesi USA, Inc. | $22.79 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151839793 | CMS |
| Janssen Pharmaceuticals, Inc | $24.63 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078115656 | CMS |
| Janssen Pharmaceuticals, Inc | $20.95 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078113918 | CMS |
| Janssen Pharmaceuticals, Inc | $35.43 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078114132 | CMS |
| Novartis Pharmaceuticals Corporation | $20.15 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087245849 | CMS |
| Novo Nordisk Inc | $22.46 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100543830 | CMS |
| Novo Nordisk Inc | $19.11 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100614901 | CMS |
| Novo Nordisk Inc | $19.82 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818416 | CMS |
| PFIZER INC. | $19.55 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131147457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.